Stepping onto that stage wasn’t easy for me. Confidence grows through action, not before it. It’s okay to feel anxious and still be capable. @IDM retreat @helmholtzmunich.bsky.social #Type2Diabetes #HostMicrobe #SGLT2Inhibitors

Impact of canagliflozin on the cardiorenal effects of dietary sodium intake in type 2 diabetes: a post hoc analysis of the CREDENCE trial - Diabetologia Aims/hypothesis Sodium–glucose cotransporter 2 (SGLT2) inhibitors provide cardiovascular and renal protection in type 2 diabetes and chronic kidney disease (CKD). Although both excess and restricted s...

Reduced sodium intake is associated with a higher risk of heart failure and cardiovascular death but this excess risk is attenuated by canagliflozin #type2diabetes #heartfailure #SGLT2inhibitors link.springer.com/article/10.1...

Today, modern drugs born from these plant defenses are taken by more nearly 200 million people - more than the combined populations of France and Germany. #metformin #SGLT2inhibitors

SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art Abstract. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce the risk of end-stage kidney disease (ESKD), cardiovascular events, and all-cause morta

SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art
#OpenAccess
Full text 👉https://buff.ly/VrurlWC

#Cardiovascular
#Haemodialysis
#PeritonealDialysis
#PeritonealMembrane
#SGLT2Inhibitors
#Nephrology
#KidneyCare
#nephsky
#medsky

Scientists reverse kidney damage with new drugs. 700M affected worldwide. For first time ever, researchers see realistic path to actual cure, not just dialysis and transplants. Golden age is here.

#KidneyDisease #ChronicKidneyDisease #Nephrology #SGLT2Inhibitors #Dialysis #USA #TheLolgic

Could SGLT-2 inhibitors do more than manage blood sugar?

A large study found an 11% lower risk of autoimmune rheumatic disease in adults with type 2 diabetes taking these drugs.

Read more: https://ow.ly/mWlh50Xkthf

#SGLT2Inhibitors #DiabetesResearch #AutoimmuneDisease

❓Can #socialmedia improve #diabetes care? ❓
Marc Evans explores its potential - along with #AI, precision prescribing & drug value of #metformin vs #SGLT2inhibitors - in the latest episode of '5 things we don't yet know about diabetes'.
📺Watch here: easd-elearning.eu/episode/351/...

Sodium-Glucose Cotransporter 2 Inhibitors for Lithium-Associated Kidney Dysfunction in Mood Disorders: A Real-World Historical Cohort Study
Abulseoud, O. A., Baweja, R. et al.
Paper
Details
#SGLT2Inhibitors #LithiumAssociatedKidneyDysfunction #MoodDisorderTreatment

New NHS diabetes strategy could raise GLP-1 drug use New guidelines on NHS management of type 2 diabetes will introduce a more personalised approach that could see expanded access to drug treatments

#NHSdiabetesstrategy #GLP1 #NHS #type2diabetes #personalisedapproach #expandedaccess #GLP1agonisttherapies #NHScosts #Individualisedcare #NICEdraftguidance #NICE #SGLT2inhibitors #GLP1receptoragonists #NICEguidance #NHS10Yearplan #patientadvocacy #DiabetesUK
pharmaphorum.com/news/new-nhs...

Join the EASD #EarlyCareer Academy this Thursday for a live webinar with Prof. Dr. Markus Laimer, as he breaks down the current evidence and future directions for #SGLT2inhibitors in #T1D - don’t miss it!

📅 8 May 2025 | 🕛 16:30 CEST

Register now 👉 us06web.zoom.us/meeting/regi...

A new review by Steven Hopkins highlights how SGLT2 inhibitors support #HeartHealth ➡️ reducing oxidative stress, enhancing mitochondrial function, & more. #SGLT2inhibitors #CardiacResearch

Learn more: journals.sagepub.com/doi/10.1177/...

💡Interested in SGLT2 inhibitors for #T1D?
Join the next #webinar featuring Prof. Markus Laimer where he reviews current evidence on the effects of #SGLT2inhibitors in T1D, highlights knowledge gaps, and explores future directions for their use.
🔗 Sign up: us06web.zoom.us/meeting/regi...

1/2: From #ACC.25 session, Do it better: raising the bar in #heartfailure care w/ practical strategies for treatment w/ #SGLT2inhibitors. From having nothing to treat #HFpEF in people with #T2DM to having therapies (SGLT2 inhibitors) that “work across the spectrum of ejection fraction.” #CardioSky

🌅 An important discovery for the management of #CKD.

The study Prof. Luigi Gnudi discusses in the latest #Gamechangers episode deals with the renal benefits of #SGLT2inhibitors beyond #diabetes.

📺👉 Watch the episode here: easd-elearning.eu/index.html@p...

Optimising use of SGLT2 inhibitors in hospital patients Introduction Sodium-glucose co-transporter-2 (SGLT2) inhibitors act on the renal proximal convoluted tubule, which inhibits SGLT2, to reduce the absorption of sodium and glucose into the blood and…

Our first learning article of 2025 explains how pharmacists can optimise SGLT2 inhibitor prescribing in hospitalised patients, ensuring safe and effective use

#SGLT2inhibitors #hospitalpharmacy

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy | NEJM Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransport...

💡 Takeaway: “SGLT2 inhibitors = renal rescue in diabetes!”

🍪 www.nejm.org/doi/full/10....

#DiabetesAndCKD #SGLT2Inhibitors #NephrologyProgress

#HeartFailure
#SGLT2Inhibitors
#HFrEF
#EvidenceBasedMedicine
#Cardiology
#PharmacistLedCare
#QualityImprovement

📖 read more here : www.kireports.org/article/S2468-0249(24)02...

#KidneyTransplant #SGLT2Inhibitors #NephrologyInnovation #TransplantCare #MedicalResearch

Innovative Treatments for Diabetes You Need to Know About


#artificialpancreas #closedloopinsulindelivery #continuousglucosemonitoring #diabetes #genetherapy #GLP1ReceptorAgonists #innovativetreatments #isletcelltransplantation #SGLT2inhibitors #smartinsulin
thediabeticwriter.com/?p=6518

Encore presentation of the EMPA-KIDNEY trial data

Speakers:🗣️ @willkidney @AdeeraLevin @MasaomiNangaku
Moderators: 👥 @pecoitsfilho @aymwanghkuhk
#ThisIsISN #ISNeducation #Nephpearls #MedTwitter #Nephrology
#SGLT2inhibitors #EMPAKidney #empagliflozin

Encore presentation of the EMPA-KIDNEY trial data

Speakers:🗣️ @willkidney @AdeeraLevin @MasaomiNangaku
Moderators: 👥 @pecoitsfilho @aymwanghkuhk
#ThisIsISN #ISNeducation #Nephpearls #MedTwitter #Nephrology
#SGLT2inhibitors #EMPAKidney #empagliflozin

🦸This is going to be an EPIC discussion. Not biased, but more power🏋🏻‍♀️ To #SGLT2inhibitors #EMPAKIDNEY #gliflozin #empagliflozin
🥇U know it when a study is stopped early for positive outcomes! 🙌🏼

x.com/ISNkidneycare/…

🦸This is going to be an EPIC discussion. Not biased, but more power🏋🏻‍♀️ To #SGLT2inhibitors #EMPAKIDNEY #gliflozin #empagliflozin
🥇U know it when a study is stopped early for positive outcomes! 🙌🏼

x.com/ISNkidneycare/…

#PaulKornerSeminar speaker @jvillanueva01 has been researching ways to increase donor heart utilisation to alleviate #transplant waitlist. Find out if #SGLT2inhibitors, typically used for #type2diabetes, can help improve #donorheart function. #WomeninSTEM #WomenInScience

#PaulKornerSeminar speaker @jvillanueva01 has been researching ways to increase donor heart utilisation to alleviate #transplant waitlist. Find out if #SGLT2inhibitors, typically used for #type2diabetes, can help improve #donorheart function. #WomeninSTEM #WomenInScience